|
KLHL20 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.800330E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.200350E-03 |
| Normal-vs-Stage2 |
4.597400E-04 |
| Normal-vs-Stage3 |
4.395000E-04 |
| Normal-vs-Stage4 |
2.164000E-03 |
| Stage1-vs-Stage2 |
1.976580E-01 |
| Stage1-vs-Stage3 |
4.417600E-01 |
| Stage1-vs-Stage4 |
4.581600E-01 |
| Stage2-vs-Stage3 |
5.009800E-01 |
| Stage2-vs-Stage4 |
6.633400E-01 |
| Stage3-vs-Stage4 |
8.776600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.411100E-04 |
| Normal-vs-AfricanAmerican |
3.383800E-01 |
| Normal-vs-Asian |
7.554000E-02 |
| Caucasian-vs-AfricanAmerican |
1.095440E-01 |
| Caucasian-vs-Asian |
3.134600E-01 |
| AfricanAmerican-vs-Asian |
5.278600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.031790E-04 |
| Normal-vs-Female |
5.622300E-04 |
| Male-vs-Female |
3.704800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.080400E-03 |
| Normal-vs-Age(41-60Yrs) |
4.032000E-04 |
| Normal-vs-Age(61-80Yrs) |
4.32329999999759E-05 |
| Normal-vs-Age(81-100Yrs) |
4.826200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.917000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.535700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.571400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.122200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.090200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.483000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.916800E-01 |
| Classical-VS-Follicular |
1.599130E-03 |
| Classical-VS-Other |
3.155600E-01 |
| Classical-VS-Normal |
6.144200E-03 |
| Tall-VS-Follicular |
1.294410E-01 |
| Tall-VS-Other |
4.443800E-01 |
| Tall-VS-Normal |
1.028440E-02 |
| Follicular-VS-Other |
9.539400E-01 |
| Follicular-VS-Normal |
1.79600999999918E-05 |
| Other-VS-Normal |
4.461900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.32510000000019E-05 |
| Normal-vs-N1 |
1.245850E-02 |
| N0-vs-N1 |
3.970800E-01 |
|
|
